References
- Batra P, Sharma AK. 2013. Anti-cancer potential of flavonoids: recent trends and future perspectives. 3 Biotech. 3(6):439–459.10.1007/s13205-013-0117-5
- Berridge MV, Herst PM, Tan AS. 2005. Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction. Biotechnol Annu Rev. 11:127–152.10.1016/S1387-2656(05)11004-7
- Freedland SJ, Humphreys EB, Mangold LA, Eisenberger M, Dorey FJ, Walsh PC, Partin AW. 2007. Death in patients with recurrent prostate cancer after radical prostatectomy: prostate-specific antigen doubling time subgroups and their associated contributions to all-cause mortality. J Clin Oncol. 25(13):1765–1771.10.1200/JCO.2006.08.0572
- Ghasemi S, Mozdarani H, Soleimani M. 2015. The effect of miR-372 on genome instability in MKN-45 cell line. J Isfahan Med Sch. 32(311):2035–2047.
- Harborne JB. 2013. The flavonoids: advances in research since 1980. Berlin: Springer.
- Jiao J, Zhang Y, Liu C, Liu J, Wu X, Zhang Y. 2007. Separation and purification of tricin from an antioxidant product derived from bamboo leaves. J Agric Food Chem. 55(25):10086–10092.10.1021/jf0716533
- Lee SK, Park YJ, Ko MJ, Wang Z, Lee HY, Choi YW, Bae Y-S. 2015. A novel natural compound from garlic (Allium sativum L.) with therapeutic effects against experimental polymicrobial sepsis. Biochem Biophys Res Commun. 464(3):774–779.10.1016/j.bbrc.2015.07.031
- Liu YY, Yang XH, Chen D, Yang JZ. 2012. Isolation and structure identification of flavonoids fromleaves of Zea mays L. J Jilin Univ, Med Ed. 38(1):67–69.
- Moheb A, Grondin M, Ibrahim RK, Roy R, Sarhan F. 2013. Winter wheat hull (husk) is a valuable source for tricin, a potential selective cytotoxic agent. Food Chem. 138(2–3):931–937.10.1016/j.foodchem.2012.09.129
- Papagiannakopoulos T, Shapiro A, Kosik KS. 2008. MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. Cancer Res. 68(19):8164–8172.10.1158/0008-5472.CAN-08-1305
- Siddiqui IA, Asim M, Hafeez BB, Adhami VM, Tarapore RS, Mukhtar H. 2011. Green tea polyphenol EGCG blunts androgen receptor function in prostate cancer. FASEB J. 25(4):1198–1207.10.1096/fj.10-167924
- Takeda M, Mizokami A, Mamiya K, Li YQ, Zhang J, Keller ET, Namiki M. 2007. The establishment of two paclitaxel-resistant prostate cancer cell lines and the mechanisms of paclitaxel resistance with two cell lines. The Prostate. 67(9):955–967.10.1002/(ISSN)1097-0045